ReShape Lifesciences Stock Quote RSLS - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

5.00

Bid

4.86

Ask

4.99

Volume

42,721

4.81 Day's Range 5.20

4.60 52 Week Range 34.22

Market Cap

3.563M

Previous Close

4.94

Open

4.99

Last Trade

4.9138

Last Trade Time

15:21:44

Financial Volume

$ 210,588

VWAP

4.9294

Average Volume (3m)

383,444

Shares Outstanding

712,680

Dividend Yield

PE Ratio

-0.31

Earnings Per Share (EPS)

-15.98

Revenue

8.68M

Net Profit

-11.39M

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.reshapelifesciences.com

Headquarters

Wilmington, Delaware, USA

Founded

ReShape Lifesciences Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker RSLS. The last closing price for ReShape Lifesciences was $4.94. Over the last year, ReShape Lifesciences shares have traded in a share price range of $ 4.60 to $ 34.22.

ReShape Lifesciences currently has 712,680 shares outstanding. The market capitalization of ReShape Lifesciences is $3.52 million. ReShape Lifesciences has a price to earnings ratio (PE ratio) of -0.31.

Form S-4/A - Registration of securities, business combinations: [Amend]

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update

Revenue Increased 16.6% in the Third Quarter of 2024 Over the Second Quarter, Representing the Third Sequential Quarter of Growth, and 6.4% Compared to the Same Period in 2023 Significant...

ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it...

ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Health...

ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes B

IRVINE, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the...

Form 8-K - Current report

Form S-4 - Registration of securities, business combinations

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.6	-10.7142857143	5.6	5.94	4.81	35830	5.3721074	CS
4	-0.39	-7.23562152134	5.39	6	4.81	115554	5.55507269	CS
12	-4.7324	-48.6252106366	9.7324	12.1299	4.6	383444	7.23656526	CS
26	-8.9142	-64.0654870564	13.9142	16.5996	4.6	951817	11.04302709	CS
52	-8.7402	-63.6104277958	13.7402	34.22	4.6	3097019	16.29220722	CS
156	-4925	-99.8985801217	4930	6438	4.6	1534726	227.59361543	CS
260	-748.13	-99.3361039927	753.13	27550	4.6	1443961	3160.10555789	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
UPCUniverse Pharmaceuticals Inc	$ 2.92 (178.10%)	91.51M
LIFWMSP Recovery Inc	$ 3.27 (105.66%)	19.69M
GXAIGaxos ai Inc	$ 2.51 (76.76%)	139.55M
SMXSMX Security Matters Public Company	$ 0.5098 (71.42%)	429.82M
SBETSharpLink Gaming Inc	$ 0.8896 (69.77%)	25.71M
ORISOriental Rise Holdings Ltd	$ 3.68 (-93.43%)	24.02M
LICNLichen China Limited	$ 0.4662 (-78.01%)	174.8M
MYNAMynaric AG	$ 0.5001 (-64.53%)	3.25M
CEROCERo Therapeutics Holdings Inc	$ 0.1157 (-39.58%)	32.65M
BJDXBluejay Diagnostics Inc	$ 4.16 (-32.90%)	409.24k
SMXSMX Security Matters Public Company	$ 0.5098 (71.42%)	429.82M
SOUNSoundHound AI Inc	$ 14.7518 (10.67%)	196.43M
LICNLichen China Limited	$ 0.4662 (-78.01%)	174.8M
NVDANVIDIA Corporation	$ 142.275 (-1.92%)	144.87M
SVMHSRIVARU Holding Ltd	$ 0.03005 (-14.14%)	143.84M